Validation of Nijmegen-Bethesda Assay Modifications to Allow Inhibitor Measurement During Replacement Therapy and Facilitate Inhibitor Surveillance

Journal of Thrombosis and Haemostasis - United Kingdom
doi 10.1111/j.1538-7836.2012.04705.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Continuous Protein Methyltransferase (G9a) Assay for Enzyme Activity Measurement and Inhibitor Screening

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2009English

Tuberculosis During TNF-α Inhibitor Therapy, Despite Screening: Table 1

Thorax
PulmonaryRespiratory Medicine
2013English

Tyrosine Kinase Inhibitor and Target Therapy

2013English

T-Cell Lymphoma Secondary to Checkpoint Inhibitor Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Hypokalemic Paralysis Secondary to Immune Checkpoint Inhibitor Therapy

Case Reports in Oncological Medicine
Oncology
2017English

F-Box Protein-Mediated Resistance to PARP Inhibitor Therapy

Molecular Cell
Cell BiologyMolecular Biology
2019English

Regarding BRAF-inhibitor Therapy of Primary Ameloblastoma

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Nuclear MedicineRadiologyOral SurgeryImagingDentistryForensic MedicinePathologySurgery
2016English

Prolonged Glucosuria and Relapse of Diabetic Ketoacidosis Related to SGLT2‐inhibitor Therapy

Endocrinology, Diabetes & Metabolism
2020English

EGFR Activation Constitutes an Adaptive Response to BRAF Inhibitor Therapy

Cancer Discovery
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy